Short sleep lowers testosterone; treating sleep apnoea does not raise it

Cut a healthy young man's sleep to five hours a night for a week and his daytime testosterone falls by 10 to 15 percent — a controlled laboratory study measured exactly that [s1]. Yet the opposite move, using a CPAP machine to fix the broken sleep of obstructive sleep apnoea, does not reliably raise testosterone at all, which points back at body weight rather than at sleep itself [s3]. Those two findings, held together, are the honest state of what sleep does to the hormone.

Testosterone in men is not a flat daily quantity. It rises during sleep, peaks in the early morning around waking, and drifts down across the day, and that overnight rise is tied to sleeping — it builds through the first hours of sleep and the onset of REM, so shortening or fragmenting the night blunts it [s2]. This is also why a proper measurement is taken in the morning: the test is meant to catch the peak that sleep produces, and a sample drawn after a bad night can read low for reasons that have nothing to do with the testes [s2].

The controlled experiment is small but clean

The clearest human evidence comes from a tightly run study of just ten men. They had a mean age of 24.3 years and spent 11 days in a laboratory: three nights of 10-hour bedtimes to establish a rested baseline, then eight nights restricted to five-hour bedtimes [s1]. Total sleep time fell from 8 hours 55 minutes to 4 hours 48 minutes, and daytime testosterone dropped by 10 to 15 percent [s1]. For scale, the study's authors noted that normal ageing lowers testosterone by only about 1 to 2 percent a year — so one week of short sleep reproduced in miniature what roughly a decade of ageing does [s1].

It is a small, young, convenience sample, and a research letter rather than a large trial, so the precise figure should not be over-read [s1]. But it is a randomised-order, within-person experiment, which is the design that can actually show sleep causing the change rather than merely tracking it — and short sleep of this kind is not exotic, being a condition the authors estimated at least 15% of the working population lives with [s1].

Fixing sleep apnoea does not restore the hormone

That looks like a clean lever: sleep more, make more testosterone. The population most affected complicates it. Men with obstructive sleep apnoea — nights of fragmented, oxygen-starved sleep — do have lower testosterone on average, and the obvious inference is that treating the apnoea should bring it back [s2]. It does not. A 2019 systematic review and meta-analysis pooled 12 studies (10 prospective cohorts and 2 randomised trials) covering 388 men and found that CPAP produced no significant change in total testosterone (mean difference 1.08, 95% CI −0.48 to 2.64) [s3].

The likely reason is obesity. Excess fat tissue both drives sleep apnoea and independently lowers testosterone, and when a man's weight does not change, treating his apnoea leaves the hormone roughly where it was [s3]. The review's authors concluded plainly that their results do not support a direct interaction between apnoea and testosterone, and that strategies other than CPAP — principally weight loss — belong at the centre of managing low testosterone in these men [s3].

What it means for a reader

The defensible reading is narrow. Chronic short sleep is a genuine, reversible suppressor of testosterone, demonstrated in a controlled experiment in young men, and there is no reason to think older men are exempt from the same physiology [s1][s2]. But testosterone is a barometer of general health, not a dial that sleep alone sets: the same low reading can come from carrying extra weight, from illness, or from the slow decline of ageing [s2]. A low morning result in a man who sleeps badly or heavily is a reason to look at the sleep and the weight first — and to repeat the test — not automatically a diagnosis.

None of this makes short sleep a treatment to be reverse-engineered, nor a substitute for evaluating low testosterone and hypogonadism properly. It does not bear on whether testosterone therapy affects fertility, and it should make a reader more sceptical of the direct-to-consumer testosterone clinics that treat a single low number as a prescription. If anything, it is a reminder that the hormone moves with how a man lives — one of several threads running through the argument over the generational decline in testosterone, much of which has little to do with the testes at all.